Polaris Venture Management Co. V as of March 31, 2020
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 10 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Phreesia | 61.2 | $68M | 3.2M | 21.03 | |
| Fate Therapeutics (FATE) | 22.9 | $25M | 1.1M | 22.21 | |
| Selecta Biosciences | 6.0 | $6.7M | 2.8M | 2.41 | |
| Kala Pharmaceuticals | 4.5 | $5.0M | 565k | 8.79 | |
| X4 Pharmaceuticals (XFOR) | 2.8 | $3.1M | 312k | 10.00 | |
| Neuronetics (STIM) | 1.3 | $1.4M | 733k | 1.89 | |
| Genocea Biosciences (GNCAQ) | 0.4 | $423k | 246k | 1.72 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $366k | 131k | 2.80 | |
| Pulmatrix | 0.3 | $363k | 359k | 1.01 | |
| Dare Bioscience | 0.3 | $277k | 326k | 0.85 |
